Here are four updates from gastroenterology companies from the past week:
Amulet Capital Partners closed the fourth private equity investment in GI June 6 when it formed US Digestive Health, a gastrointestinal-focused practice management organization. Read more.
SeekingAlpha analyzed CRH Medical, offering insights into the company's recent history and predictions on its future.
The FDA granted Motus GI 510(k) approval for Pure-Vu Gen 2, the newest iteration of its colonoscopy preparation system.
Uthra Sundaram, senior vice president of Takeda's gastrointestinal business unit, shared insights into the company's focus on GI, its drug pipeline and how the company's acquisition of Shire has been received. Read more.